Tatjana Pandzic
Uppsala, C, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Low Rate of Germline Investigation for Variants of Suspected Germline Origin Detected During the Diagnostic Work-Up of Myeloid Neoplasms.
Journal: EJHaem
Published: October 17, 2025
A novel PML germline variant as a candidate predisposing genetic aberration in familial acute myeloid leukaemia.
Journal: British journal of haematology
Published: May 19, 2025
MALNC: a new mutant NPM1/IDH2R140 and PML-RARA-associated lncRNA with impact on AML cell proliferation, maturation and drug response.
Journal: Cancer gene therapy
Published: March 28, 2025
Validation of Guidelines for Genetic Investigation of Myeloid Neoplasms with Germline Predisposition: Results from a Prospective Cohort Study.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 17, 2024
Micro-costing of genetic diagnostics in acute leukemia in Sweden: from standard-of-care to whole-genome sequencing.
Journal: Journal of medical economics
Published: August 05, 2024
Precision Diagnostics in Myeloid Malignancies: Development and Validation of a National Capture-Based Gene Panel.
Journal: Genes, chromosomes & cancer
Published: May 07, 2024
Patient-Specific Measurable Residual Disease Markers Predict Outcome in Patients With Myelodysplastic Syndrome and Related Diseases After Hematopoietic Stem-Cell Transplantation.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 17, 2024
Cancer associated variant enrichment CAVE, a gene agnostic approach to identify low burden variants in chronic lymphocytic leukemia.
Journal: Scientific reports
Published: January 11, 2024
Pathogenic DDX41 variants, possible response predictors to low-dose melphalan in hypo- and normocellular MDS and AML.
Journal: British journal of haematology
Published: August 20, 2023
BTK and PLCG2 remain unmutated in one-third of patients with CLL relapsing on ibrutinib.
Journal: Blood advances
Published: August 24, 2022
Familial platelet disorder due to germline exonic deletions in RUNX1: a diagnostic challenge with distinct alterations of the transcript isoform equilibrium.
Journal: Leukemia & lymphoma
Published: May 09, 2022
Last Updated: 09/26/2026